cGxP.wire https://validator.w3.org/feed/docs/rss2.html Neurocrine Launches CAH Education Tools for Healthcare Teams INOVIO Wins FDA Approval for VOCERYQ in RRP Treatment Flagship Launches Etcelera to Transform AI Drug Discovery Eloxx Wins FDA IND Clearance for Exaluren in ADPKD ADC Therapeutics Advances ZYNLONTA Japan Approval Filing Nuvation Bio Expands Phase 3 Safusidenib Trial Across Europe Altruist Biologics Advances NMPA Review for Localized Production Sun Pharma Wins FDA Approval for ILUMYA in Psoriatic Arthritis Daiichi Sankyo Seeks EU Approval for Triple Lipid Therapies CereVasc Wins FDA IDE Approval for Alzheimer’s eShunt Trial Asymchem Completes First USFDA Inspection at Tianjin 4 Site OncoC4 to Present New Cesalatamig Data at SITC 2026 Meeting! Novavax Earns $125M as Sanofi Starts Phase 3 Vaccine Trial Kimberly-Clark Completes Kenvue Acquisition, Expands Health Review Examines Linoleic Acid-Rich Oils and Health Outcomes! U.S. Renal Care Presents Eight Kidney Research Studies at ASN Resonant Launches Sample Asset Management Programs for Trial CoSara HPV Test Study Highlights Cervical Cancer Screening Novo Nordisk to Present 26 Obesity Data Abstracts at 2026 Instylla Wins FDA Approval for Embrace Bleeding Device Azitra Expands ATR-04 Trial for Cancer-Related Skin Rashes Abbott Launches Pivotal Trial of Cephea Mitral Valve Johnson & Johnson Presents 26 Impella Studies at TCT 2026! BioMarin Licenses Next-Gen Fabry Disease Therapy Worldwide Sobi Reports Positive Phase 3 Pozdeutinurad Gout Data US WorldMeds Acquires Orbus to Advance Glioma Drug Research Eli Lilly Retatrutide Shows Strong Phase 3 Diabetes Results! Palvella Gains FDA Priority Review for QTORIN Rapamycin NDA! Novo Nordisk to Present 12 New Liver Research Abstracts HotSpot Therapeutics to Present HST-2011 Autoimmune Data Avenzo to Present AVZO-023 Phase 1 Results at SABCS 2026 Immunome Receives EMA Validation for Varegacestat Application Propanc Advances PPC-001 Assay Development for Phase 1b Cancer Study Moleculin Completes MIRACLE Trial Part A Dosing in R/R AML Atsena Reports Promising ATSN-301 Preclinical Data for Usher 1B Syndax’s Revuforj Wins 2026 Prix Galien Rare Disease Award Pelthos to Merge With Castle Creek, Expanding Skin Disease Pipeline Denali Therapeutics Wins 2026 Prix Galien Award for AVLAYAH Setara Biosciences Raises $90M Series A to Advance Rare Disease Drugs Alkermes Initiates Phase 2 Study of ALKS 7290 in Depression Latus Bio Reports Engineered AAV Capsid Data for Kidney and CNS Diseases Brainomix AI Finds Stroke Signals in CHARM Phase 3 Trial Genprex to Present TUSC2 Gene Research at GSA 2026 Meeting Formation Bio Launches $600M Fund to Advance Drug Development Agios Sets February 2027 FDA Goal Date for Mitapivat in Sickle Cell Disease Boehringer Ingelheim Launches Metabolic Matters Initiative HERVolution Advances HERV-K Cancer Immunotherapy Research NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine Acumen Pharmaceuticals Ends Sabirnetug Development After Phase 2 Failure Leads Biolabs Doses First SLE Patient in LBL-047 Phase 1 Trial